According to a new study at Stanford University, a once-a-day pill to prevent HIV infection could significantly reduce the spread of the AIDS-causing virus, but would only be cost-effective if limited to men at very high risk for HIV infection.
Researchers created an economic model to analyze the use of the combination drug tenofovir-emtricitabine (brand name […]
continue reading from " HIV prevention pill for high-risk men "
